Needham & Company raised its price target on Globus Medical (NYSE: GMED) to $58.00 (from $57.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Globus Medical (GMED) PT Raised to $58 at Morgan StanleyMay 3, 2018 7:36 AM Globus Medical (GMED) PT Raised to $56 at Piper JaffrayMay 3, 2018 6:25 AM Increasing unusual option volume: GMED TAHO PVH TAP ESPR MAN NGD WFT IRWD DM ADNTMay 3, 2018 5:38 AM Globus Medical (GMED) PT Raised to $58 at Canaccord GenuityMay 3, 2018 1:00 AM Form 8-K GLOBUS MEDICAL INC For: May 02May 2, 2018 4:52 PM Globus Medical (GMED) Tops Q1 EPS by 5c; Raises OutlookMay 2, 2018 4:26 PM Globus Medical Reports First Quarter 2018 ResultsMay 2, 2018 4:15 PM